Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
V127296-5mg | 5mg | In stock | $236.90 | |
V127296-25mg | 25mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $1,066.90 |
Synonyms | VERLUKAST|120443-16-5|MK-679|MK-0679|CHEMBL280481|5Q9O54P0H7|L-668,019|Verlukastum|L-668019|MK 679|(R,E)-3-(((3-(2-(7-chloroquinolin-2-yl)vinyl)phenyl)((3-(dimethylamino)-3-oxopropyl)thio)methyl)thio)propanoic acid|Propanoic acid, 3-(((3-(2-(7-chloro-2-qu |
---|---|
Specifications & Purity | Moligand™, ≥98% |
Biochemical and Physiological Mechanisms | Verlukast(MK-679; L 668019) is a receptor antagonist for the treatment of respiratory diseases. |
Storage Temp | Store at -20°C |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | ANTAGONIST, INHIBITOR |
Mechanism of action | Antagonist of CysLT 1 receptor;Inhibitor of OATP2B1 |
Product Description | Product Application: A receptor antagonist for the treatment of respiratory diseases. |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
IUPAC Name | 3-[(R)-[3-[(E)-2-(7-chloroquinolin-2-yl)ethenyl]phenyl]-[3-(dimethylamino)-3-oxopropyl]sulfanylmethyl]sulfanylpropanoic acid |
---|---|
INCHI | InChI=1S/C26H27ClN2O3S2/c1-29(2)24(30)12-14-33-26(34-15-13-25(31)32)20-5-3-4-18(16-20)6-10-22-11-8-19-7-9-21(27)17-23(19)28-22/h3-11,16-17,26H,12-15H2,1-2H3,(H,31,32)/b10-6+/t26-/m1/s1 |
InChi Key | AXUZQJFHDNNPFG-LHAVAQOQSA-N |
Canonical SMILES | CN(C)C(=O)CCSC(C1=CC=CC(=C1)C=CC2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O |
Isomeric SMILES | CN(C)C(=O)CCS[C@@H](C1=CC=CC(=C1)/C=C/C2=NC3=C(C=CC(=C3)Cl)C=C2)SCCC(=O)O |
PubChem CID | 6509849 |
Molecular Weight | 515.09 |
CAS Registry No. | 120443-16-5 |
---|---|
PubChem CID | 6509849 |
ChEMBL Ligand | CHEMBL280481 |
Reactome Reaction | R-HSA-9684627 |
Reactome Drug | R-ALL-9684617 |
GPCRdb Ligand | verlukast |
Enter Lot Number to search for COA:
Solubility | DMSO (Slightly), Methanol (Slightly, Heated, Sonicated), THF (Slightly, Sonicate) |
---|---|
Melt Point(°C) | 57-62°C |
1. Jones TR, Zamboni R, Belley M, Champion E, Charette L, Ford-Hutchinson AW, Gauthier JY, Leger S, Lord A, Masson P et al.. (1991) Pharmacology of the leukotriene antagonist verlukast: the (R)-enantiomer of MK-571.. Can J Physiol Pharmacol, 69 (12): (1847-54). [PMID:1666333] |